Meghalaya Magazine

Helicobacter Pylori Infections Treatment Market is anticipated to grow at a significant CAGR for the study period (2019-32). Key Companies – Phathom Pharmaceuticals, Sequella, CJ Healthcare, Imevax, C

 Breaking News
  • No posts were found

Helicobacter Pylori Infections Treatment Market is anticipated to grow at a significant CAGR for the study period (2019-32). Key Companies – Phathom Pharmaceuticals, Sequella, CJ Healthcare, Imevax, C

June 06
19:32 2022
Helicobacter Pylori Infections Treatment Market is anticipated to grow at a significant CAGR for the study period (2019-32). Key Companies - Phathom Pharmaceuticals, Sequella, CJ Healthcare, Imevax, C
Helicobacter Pylori Infections Treatment Market

(Albany, US) DelveInsight’s “Helicobacter Pylori Infections Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Helicobacter Pylori Infections, historical and forecasted epidemiology as well as the Helicobacter Pylori Infections market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.


Some facts of Helicobacter Pylori Infections Market are:

  • A study titled “Epidemiology of Helicobacter pylori in an Asymptomatic Population in the United States,” conducted by David et al., showed that the prevalence of H. pylori infection increased rapidly with age at one percent per year for the overall population.
  • The study by Sitas et al., titled “Helicobacter pylori infection rates in relation to age and social class in a population of Welsh men,” estimates that overall prevalence of H. pylori was 56.9%, increasing sharply in middle age from 29.8% in those aged 30–34 to over 59% in those aged 45 or older.
  • As per the study titled “A 5-year trend of Helicobacter pylori seroprevalence among dyspeptic patients at Bahir Dar Felege Hiwot Referral Hospital, Northwest Ethiopia” conducted by Meseret et al., the seroprevalence of H. pylori was significantly higher in males (43.2%) than in females (39.9%).
  • As per the study conducted by Campbell et al. (2005), approximately 0.5% of the UK population (around 290 thousand people, 20% of all general practice workload) are on long-term acid suppression because of peptic ulcer-related diseases which are attributable to chronic H. pylori infection.
  • According to Everhart et al., the prevalence of H. pylori is higher in Hispanics, African Americans, and the elderly. Its prevalence is 60% in Hispanics, 54% in African Americans, and 20% in Whites. The estimated prevalence is 20% for people younger than 30 years and 50% for those older than 60 years in the United States.


Get more comprehensive insights into how Helicobacter Pylori Infections epidemiological trends are impacting current and forecasted Helicobacter Pylori Infections market @ Helicobacter Pylori Infections Epidemiology Analysis and Forecast


Scope of the Helicobacter Pylori Infections Market Report

  • The report covers the descriptive overview of Helicobacter Pylori Infections, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
  • Comprehensive insight has been provided into the Helicobacter Pylori Infections epidemiology and treatment in the 7MM
  • Additionally, an all-inclusive account of both the current and emerging therapies for Helicobacter Pylori Infections are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
  • A detailed review of Helicobacter Pylori Infections market; historical and forecasted is included in the report, covering drug outreach in the 7MM
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Helicobacter Pylori Infections market


Some of the Helicobacter Pylori Infections Companies:

  • Phathom Pharmaceuticals
  • Sequella
  • CJ Healthcare
  • Imevax
  • Crestone
  • And Many Others


Request for Sample Copy:


Helicobacter Pylori Infections is a common type of bacteria that grows in the digestive tract and has a tendency to attack the stomach lining. It infects the stomachs of roughly 60 percent of the world’s adult population. H. pylori infections are usually harmless, but they’re responsible for the majority of ulcers in the stomach and small intestine. The “H” in the name is short for Helicobacter. “Helico” means spiral, which indicates that the bacteria are spiral shaped.


Helicobacter Pylori Infections Symptoms

The symptoms associated with Helicobacter Pylori Infections include:

  • An ache or burning pain in abdomen
  • Abdominal pain that’s worse when the stomach is empty
  • Nausea
  • Loss of appetite
  • Frequent burping
  • Bloating
  • Unintentional weight loss


Helicobacter Pylori Infections Causes

It’s still not known exactly how H. pylori infections spread. The bacteria have coexisted with humans for many thousands of years. The infections are thought to spread from one person’s mouth to another. They may also be transferred from feces to the mouth. This can happen when a person does not wash their hands thoroughly after using the bathroom. H. pylori can also spread through contact with contaminated water or food.


Some of Helicobacter Pylori Infections Drugs Covered:

  • Vonoprazan
  • SQ 109
  • Tegoprazan
  • IMX 101
  • CRS3123
  • And Many Others



Table of Contents:

1. Key Insights

2. Executive Summary of Helicobacter Pylori Infections

3. Competitive Intelligence Analysis for Helicobacter Pylori Infections

4. Helicobacter Pylori Infections: Market Overview at a Glance

5. Helicobacter Pylori Infections: Disease Background and Overview

6. Patient Journey

7. Helicobacter Pylori Infections Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Unmet Needs

10. Key Endpoints of Helicobacter Pylori Infections Treatment

11. Marketed Products

12. Emerging Therapies

13. Helicobacter Pylori Infections: Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Helicobacter Pylori Infections

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer



About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States